← Back to Search

Patient Reported Outcome Measure for Opioid Use Disorder (RecoveryPROM Trial)

N/A

Waitlist Available

Led By Sharon Reif, PhD

Research Sponsored by Brandeis University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months after baseline, 6 months after baseline

Awards & highlights

RecoveryPROM Trial Summary

This trial will test a new patient-reported outcome measure to see if it is useful and acceptable to patients and clinicians, and if it leads to improved outcomes for people with substance use disorders.

Eligible Conditions

Opioid Use Disorder
Substance Use Disorder

RecoveryPROM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months after baseline, 6 months after baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months after baseline, 6 months after baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after baseline, 6 months after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in number of days mental/physical health were not good (in past 30 days), assessed via CDC HRQOL questionnaire.

Change in patient-clinician alliance, assessed via WAI-SR

Change in reported health related quality of life (4-point scale), assessed via CDC HRQOL questionnaire

+1 more

Secondary outcome measures

Social determinants of health, assessed via PRAPARE

Substance use past 30 days, assessed via modified ASI Alcohol and Drug module

Other outcome measures

Satisfaction with Recovery PROM

RecoveryPROM Trial Design

1Treatment groups

Experimental Treatment

Group I: Recovery PROMExperimental Treatment1 Intervention

All study participants will complete the Recovery PROM instrument.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Brandeis UniversityLead Sponsor

21 Previous Clinical Trials

13,827 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,465 Previous Clinical Trials

2,618,533 Total Patients Enrolled

Stanley Street Treatment and Resources (SSTAR)UNKNOWN

1 Previous Clinical Trials

417 Total Patients Enrolled

Media Library

Patient Reported Outcome Measure Clinical Trial Eligibility Overview. Trial Name: NCT05388045 — N/A

Opioid Use Disorder Research Study Groups: Recovery PROM

Opioid Use Disorder Clinical Trial 2023: Patient Reported Outcome Measure Highlights & Side Effects. Trial Name: NCT05388045 — N/A

Patient Reported Outcome Measure 2023 Treatment Timeline for Medical Study. Trial Name: NCT05388045 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are the protocols of this trial still open to participants?

"This particular research study is no longer accepting participants, as shown on clinicaltrials.gov; the trial was originally posted on April 14th 2022 and last updated July 19th 2022. However, there are 1351 other medical trials actively seeking patients at this moment in time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Piloting a Patient-Reported Outcome Measure for Opioid Use Disorder Recovery in a Clinical Setting

Sharon Reif 2022. "Piloting a Patient-Reported Outcome Measure for Opioid Use Disorder Recovery in a Clinical Setting". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05388045.